Skip to main content
BJS Open logoLink to BJS Open
. 2020 Oct 13;4(6):1256–1265. doi: 10.1002/bjs5.50350

Role of circulating fibrocytes in the diagnosis of acute appendicitis

M A Zarog 1,2, D P O'Leary 1, M G Kiernan 1,2, J Bolger 1, P Tibbitts 1,2, S N Coffey 1, A Lowery 1,2, G J Byrnes 1,2, C Peirce 1,2, C P Dunne 2,3, J C Coffey 1,2,3,
PMCID: PMC7709380  PMID: 33047514

Abstract

Background

Improved diagnostic biomarkers are required for acute appendicitis. The circulating fibrocyte percentage (CFP) is increased in inflammatory states, but has not been studied in acute appendicitis. This study aimed to determine CFP in acute appendicitis and compare diagnostic accuracy with standard serological biomarkers.

Methods

A prospective cohort study was carried out between June 2015 and February 2016 at University Hospital Limerick. The CFP was determined by dual‐staining peripheral venous samples for CD45 and collagen I using fluorescence‐activated cell sorting, and correlated with histopathological diagnoses. The accuracy of CFP in determining histological acute appendicitis was characterized and compared with the white cell count, C‐reactive protein concentration, neutrophil count, lymphocyte count and neutrophil : lymphocyte ratio.

Results

Of 95 adults recruited, 15 were healthy individuals and 80 had suspected appendicitis at presentation. Forty‐six of these 80 patients had an appendicectomy, of whom 34 had histologically confirmed appendicitis. The CFP was statistically higher in patients with pathologically proven acute appendicitis than in healthy controls (median 6·1 (i.q.r. 1·6–11·6) versus 2·3 (0·9–3·4) per cent respectively; P = 0·008). The diagnostic accuracy of CFP, as determined using the area under the receiver operating characteristic (ROC) curve, was similar to that of standard biomarkers. In multinomial regression analysis, only raised CFP was retained as an independent prognostic determinant of acute appendicitis (odds ratio 1·57, 95 per cent c.i. 1·05 to 2·33; P = 0·027).

Conclusion

The CFP is increased in histologically confirmed acute appendicitis and is as accurate as standard serological biomarkers in terms of diagnosis.


The circulating fibrocyte percentage is increased in patients with acute appendicitis. This may improve diagnostics, and reduce unnecessary radiation exposure and surgical operations.

graphic file with name BJS5-4-1256-g007.jpg

Circulating fibrocyte percentage may help in diagnosis of acute appendicitis.

Introduction

Suspected acute appendicitis is the most common cause of acute surgical admission 1 . Despite the frequency with which the condition is encountered, accurate diagnosis of acute appendicitis continues to present a clinical challenge 2 . This is due mainly to the overlap of characteristic symptoms and signs with other intra‐abdominal conditions, such as mesenteric adenitis and ovarian pathology 3 , 4 , 5 , 6 . This diagnostic dilemma is reflected in reported negative appendicectomy rates (NARs) that can be as high as 30 per cent in patients who undergo surgery 7 , 8 . These reported NARs highlight the limitations of current diagnostic tests and emphasize the need for an accurate preoperative test.

A number of studies have previously investigated the use of biomarkers including white cell count (WCC) and C‐reactive protein (CRP) in the diagnosis of acute appendicitis 9 , 10 , 11 , 12 . Although these biomarkers are associated with low costs and are universally available, they have been criticized for lack of diagnostic accuracy in acute appendicitis 13 , 14 , 15 , 16 . The neutrophil : lymphocyte ratio (NLR) is another simple biomarker generated from the differential white blood cells. Studies 17 , 18 have demonstrated that NLR is a useful predictor of complicated appendicitis, but has a limited diagnostic role in acute appendicitis.

Radiological investigations such as CT, MRI and ultrasound imaging have improved the diagnostic accuracy of acute appendicitis and reduced the NAR 19 , 20 , 21 . However, exposing patients to high levels of radiation associated with standard CT carries an increased lifetime risk of developing certain cancer subtypes 22 , 23 . Despite this, there is emerging evidence that low‐dose CT with intestinal contrast, a standard protocol in the investigation of appendicitis, allows highly accurate diagnostic with low radiation exposure 24 , 25 . Ultrasound examination, on the other hand, is a less expensive and radiation‐free form of imaging. However, it is operator‐dependent and has a lower sensitivity for acute appendicitis than MRI and CT 26 , 27 .

Circulating fibrocytes are haematopoietic cells derived from the bone marrow that circulate in the monocyte fraction and can differentiate into myelofibrocytes, fibroblasts and adipocytes 28 , 29 . They have a prominent role in both inflammatory and healing processes 30 , 31 . Previous work by the authors' group has demonstrated that circulating fibrocytes are increased in the mesentery in Crohn's disease, where they appear to migrate across the mesentery to access the serosal surface of the intestine 32 . They produce numerous cytokines such as tumour necrosis factor (TNF) α, interleukin (IL) 6, IL‐8 and IL‐10, and actively contribute to tissue remodelling by secreting fibrogenic and angiogenic growth factors such as fibroblast growth factor, endothelin 1, vascular endothelial growth factor, platelet‐derived growth factor A and macrophage colony‐stimulating factor 30 . The circulating fibrocyte percentage (CFP) has been shown to provide valuable diagnostic and prognostic information in inflammation‐based disease processes, including idiopathic pulmonary fibrosis and bronchial asthma 33 , 34 .

The CFP has also been speculated to play a key role in the pathogenesis of primary and secondary mesenteropathies 35 , 36 . To date, no studies have examined the role of CFP in the diagnosis of acute appendicitis. Thus, the initial aim of the study was to compare the CFP in patients with acute appendicitis and healthy controls. The diagnostic accuracy of CFP in diagnosing acute appendicitis compared with standard serological biomarkers was also assessed.

Methods

A prospective cohort study was undertaken in patients aged over 16 years presenting acutely with suspected appendicitis at University Hospital Limerick, Ireland between 10 June 2015 and 14 February 2016. Blood samples were also taken from healthy controls. The diagnosis of appendicitis was confirmed by histopathological assessment after appendicectomy. Ethical approval was obtained from the Research Ethics Committee and the Quality and Patient Safety Department at University Hospital Limerick (record number 109/15), and the study was registered at ClinicalTrials.gov (NCT03988660).

A venous blood sample was collected from patients after obtaining written informed consent. Patients who had an appendicectomy were divided into three groups: patients with a histologically proven appendicitis; patients with a histologically proven normal appendix; and patients with an alternative diagnosis. Two patients had radiological features of inflammation in the right iliac fossa (1 phlegmon and 1 para‐appendiceal abscess). These patients did not have surgical intervention owing to surgeon preference, and both were included in the alternative diagnosis group.

When the appendix appeared macroscopically normal at laparoscopy, it was left to the operating surgeon to decide whether an appendicectomy was required.

Data collection included date of admission, patient's sex, age, presenting symptoms, duration of symptoms, percentage of fibrocytes in circulating white cells (CFP), preoperative WCC and differentials (NLR and neutrophil, lymphocyte, monocyte, basophil and eosinophil counts), CRP level, operation performed, clinical diagnosis and postoperative histological diagnosis.

Blood sample collection, preparation and processing

Peripheral venous samples were obtained from patients. A single 10‐ml sample of heparinized venous blood was collected via peripheral arm venepuncture. Samples were collected in sodium heparin (EDTA) vacutainer tubes and transferred to the laboratory at the University of Limerick. Samples were then processed to isolate the buffy coat layer using density gradient centrifugation (Histopaque®; Sigma‐Aldrich, Wicklow, Ireland). The resulting peripheral blood mononuclear cells were subsequently washed in phosphate‐buffered saline (PBS) and resuspended in freezing medium (50 per cent fetal bovine serum, 40 per cent RPMI medium and 10 per cent dimethyl sulphoxide) before transfer to cryogenic vials in 1‐ml aliquots. Finally, samples were cooled in a cryogenic temperature control rate container to −80°C until processing for flow cytometry.

Sample processing for flow cytometry

After white blood cell isolation using density gradient centrifugation, 1 × 106 cells were resuspended in flow cytometry buffer (RPMI medium supplemented with 10 per cent horse serum, 0·1 per cent sodium azide and 25 mmol/l HEPES). Cells were fixed and permeabilized using BD Cytofix/Cytoperm™ solution (BD Biosciences, Oxford, UK) and blocked before intracellular staining of collagen I with mouse antihuman collagen I antibody (product code MAB3391; Millipore, Cork, Ireland). These were then stained with Alexa Fluor® 488 goat antimouse secondary antibody (product code 115‐545‐146; Jackson ImmunoResearch Europe, Newmarket, UK). Cells were finally stained for cell surface antigen CD45 using PerCP® anti‐human CD45 (BioLegend, London, UK) and resuspended in PBS before subsequent analysis 37 , 38 , 39 . All analysis was done on a BD FACSVerse™ flow cytometer (BD Biosciences) using BD FACSuite™ v1.0.5 (BD Biosciences). Circulating fibrocyte levels were displayed as a percentage of the total white blood cell population (CFP).

Missing data

Patients presenting with suspected appendicitis who had incomplete data were not included in the final analysis.

Statistical analysis

Data analysis was performed using IBM SPSS® for Mac OSX Version 25.0 (IBM, Armonk, New York, USA). Data are presented as mean(s.d.) or median (i.q.r.) values, as appropriate. The distribution of variables was assessed by histograms, Q–Q plots and box plots. One‐way ANOVA was used to compare different independent groups. Independent t‐test was utilized to compare normally distributed data. Kruskal–Wallis and Mann–Whitney U tests were used to compare the biomarkers between the different groups (appendicitis versus normal appendix versus alternative diagnosis versus healthy controls). P < 0·050 was considered statistically significant. Pearson's correlation test was used to evaluate the relationship between the variables. Receiver operating characteristic (ROC) curves were used to characterize and compare the diagnostic accuracy of percentage fibrocytes in circulating white cells, WCC, CRP level, neutrophil count, NLR and monocyte count. Multinomial logistic regression analysis was used to assess for an independent predictor of histologically acute appendicitis.

Results

A total of 95 participants were recruited into the study (51 female and 44 male patients). Data were incomplete for two patients presenting with suspected appendicitis ( Fig. S1 , supporting information). The study cohort was separated into the 80 patients with a clinical suspicion of acute appendicitis, and 15 healthy adult controls, who were asymptomatic with no underlying chronic medical conditions or history of appendicectomy, were recruited. Of the 80 patients presenting with suspected appendicitis, 37 (46 per cent) were men and 43 (54 per cent) were women.

Patient demographics are presented in Table  1 and Fig. S1 (supporting information). Forty‐six (58 per cent) of the 80 patients underwent laparoscopic appendicectomy, with no conversions to open surgery. Of these, 34 patients had histologically proven acute appendicitis (23 men and 11 women; P = 0·040). The remaining 12 patients had a normal appendix on histological assessment. The overall NAR was 26 per cent (12 of 46 patients): six of 29 in men versus six of 17 in women (P = 0·314) (Table  1 ).

Table 1.

Summary of patient demographics

Men (n = 44) Women (n = 51) P
Total (%) 46·3 53·7 0·473
Age (years)* 32·5(14·2) 36·3(13·6) 0·190
Healthy controls 7 (47) 8 (53) 0·796
Histologically proven appendicitis 23 (68) 11 (32) 0·040
Histologically proven normal appendix 6 (50) 6 (50) 0·100
Alternative diagnosis 8 (24) 26 (76) 0·002
Negative appendicectomy rate 6 of 29 (21) 6 of 17 (35) 0·314

Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.).

χ2 test, except

independent t test.

Thirty‐four (43 per cent) of the 80 patients had a final alternative diagnosis, and were treated conservatively. Of these 34 patients, 16 were diagnosed with non‐specific abdominal pain and four had ovarian pathology (Table  2 ). One patient was diagnosed with a phlegmon (involving the appendix, terminal ileum and related regions of mesentery) in the right iliac fossa, and another had a periappendiceal abscess. As these latter two patients were diagnosed radiologically and treated without surgery, they were included in the alternative diagnosis group.

Table 2.

Patients with alternative diagnoses

No. of patients (n = 34)
Non‐specific abdominal pain 16
Ovarian pathology 4
Diverticulitis 2
Terminal ileitis 1
Uterine fibroids 1
Ureteric stone 1
Constipation 1
Urinary tract infection 1
Mesenteric adenitis 1
Acute cholecystitis 1
Adhesions 1
Colonic tumour 1
Subcutaneous haematoma 1
Appendicular mass 1
Appendicular abscess 1

Association of circulating fibrocyte percentage and appendiceal inflammation

Median CFP in white cells was significantly higher in patients with acute appendicitis than in either healthy controls, patients with a normal appendix or patients with alternative diagnoses: 6·1 (i.q.r. 1·6–11·6) versus 2·3 (0·9–3·4), 1·7 (0·3–2·7) and 2·9 (1·4–5·8) per cent respectively (P = 0·003) (Figs  1 , 2 , 3 ).

Fig. 1.

BJS5-50350-FIG-0001-c

Q–Q plots of circulating fibrocyte percentage in patients with acute appendicitis and those with a normal appendix a Acute appendicitis group; b normal appendix group.

Fig. 2.

BJS5-50350-FIG-0002-c

Scatter plots demonstrating differences in the percentage of circulating fibrocytes between a healthy individual and a patient with acute appendicitis a Healthy control: circulating fibrocyte percentage (CFP) 2·6 per cent. b Patient with acute appendicitis: CFP 8·0 per cent. UL, upper left; UR, upper right; LL, lower left; LR, lower right.

Fig. 3.

BJS5-50350-FIG-0003-c

Bar chart summarizing circulating fibrocyte percentage in histologically proven normal appendix group, histologically proven appendicitis group, alternative diagnosis group and healthy controls Median values, interquartile ranges and ranges (excluding outliers (○) and extreme values (*)) are denoted by horizontal bars, boxes and error bars respectively.

Association of standard serological biomarkers and appendiceal inflammation

Standard serological biomarker levels were determined for all 80 patients presenting with suspected appendicitis. Levels of each biomarker were compared between groups in multivariable analysis. Most serological concentrations of biomarkers were raised in patients presenting with suspected appendicitis (Table  3 ).

Table 3.

Summary of biomarker values in patients presenting with suspected appendicitis

Histologically proven normal appendix Histologically proven inflamed appendix Alternative diagnosis P *
WCC (106/μl) 7·0 (6·2–10·7) 11·7 (8·2–15·5) 8·5 (7·5–11·1) 0·005
CRP (mg/l) 4·0 (4·0–10·0) 16·5 (6·0–35·5) 7·0 (4·0–33·5) 0·016
Neutrophils (106/μl) 4·3 (3·5–8·6) 9·3 (5·3–12·9) 5·6 (4·7–9·3) 0·004
Lymphocytes (106/μl) 1·8 (1·5–2·6) 1·3 (1·0–2·0) 1·7 (1·4–2·2) 0·067
NLR 2·2 (1·9–4·7) 7·1 (2·6–12·5) 3·6 (2·0–5·9) 0·004
Monocytes (106/μl) 0·39 (0·33–0·54) 0·56 (0·41–0·74) 0·44 (0·39–0·57) 0·010
Basophils (106/μl) 0·04 (0·04–0·08) 0·05 (0·03–0·06) 0·04 (0·03–0·06) 0·559
Eosinophils (106/μl) 0·16 (0·10–0·24) 0·12 (0·06–0·20) 0·14 (0·10–0·26) 0·167

Values are median (i.q.r.). WCC, white cell count; CRP, C‐reactive protein; NLR, neutrophil : lymphocyte ratio.

*

Kruskal–Wallis test.

Correlation of circulating fibrocyte levels and standard serological biomarkers

After the analysis of diagnostic accuracy analysis, a correlation analysis was performed to assess the relationships between the different biomarkers. There were significant positive linear correlations between CFP and both WCC (r = 0·34, P = 0·002) and neutrophils (r = 0·33, P = 0·003) ( Fig. S2 , supporting information). However, this linear relationship was not apparent between CFP and CRP level, NLR, monocyte count, age or sex in patients presenting with suspected appendicitis ( Fig. S3 , supporting information).

Association of duration of symptoms and circulating fibrocyte percentage

The relationship between duration of symptoms and CFP was assessed in patients with histologically confirmed acute appendicitis. Symptoms were stratified as having a duration from onset of less than 48 h and 48 h or more. Although there was a difference between median CFP values (3·3 versus 8·4 per cent respectively), this was not statistically significant (P = 0·521) (Fig 4 ).

Fig. 4.

BJS5-50350-FIG-0004-c

Association between duration of symptoms and circulating fibrocyte percentage in patients with acute appendicitisMedian values, interquartile ranges and ranges (excluding outliers (○) and extreme values (*)) are denoted by horizontal bars, boxes and error bars respectively.

Diagnostic accuracy of circulating fibrocyte percentage in acute appendicitis

The accuracy of CFP in diagnosing acute appendicitis was determined and compared with that of other biomarkers using ROC curve analysis (Fig 5 ). The performance of CFP was similar to that of the other biomarkers analysed (Table  4 ).

Fig. 5.

BJS5-50350-FIG-0005-c

Receiver operating characteristic (ROC) curves for six biomarkers ROC curves for circulating fibrocyte percentage (CFP), white cell count (WCC), C‐reactive protein (CRP), neutrophils, neutrophil : lymphocyte ratio (NLR) and monocytes are shown.

Table 4.

Comparison of diagnostic accuracy for different biomarkers

Threshold value AUC P Sensitivity (%) Specificity (%) PPV (%) NPV (%)
CFP (%) 3·1 0·70 0·003 68·8 (50·0, 83·9) 68·2 (52·4, 81·4) 61·1 (49·0, 72·0) 75·0 (63·3, 83·9)
WCC (106/μl) 10·7 0·68 0·006 56·3 (37·7, 73·6) 75·0 (59·7, 86·9) 62·1 (47·4, 74·8) 70·2 (60·6, 78·3)
CRP (mg/l) 9·0 0·65 0·025 68·8 (50·0, 83·9) 61·4 (45·5, 75·6) 56·4 (45·5, 66·8) 73·0 (60·6, 82·6)
Neutrophils (106/μl) 7·2 0·69 0·004 65·6 (46·8, 81·4) 65·9 (50·1, 79·5) 58·3 (46·4, 69·4) 72·5 (61·0, 81·7)
NLR 4·4 0·69 0·005 59·4 (40·6, 76·3) 63·6 (47·8, 77·6) 54·3 (42·2, 65·9) 68·3 (57·3, 77·6)
Monocytes (106/μl) 0·5 0·67 0·010 62·5 (43·9, 78·9) 68·2 (52·4, 81·4) 58·8 (46·2, 70·4) 71·4 (60·5, 80·3)

Values in parentheses are 95 per cent confidence intervals. AUC, area under the receiver operating characteristic (ROC) curve; PPV, positive predictive value; NPV, negative predictive value; CFP, circulating fibrocyte percentage; WCC, white cell count; CRP, C‐reactive protein; NLR, neutrophil : lymphocyte ratio.

Association of circulating fibrocyte percentage and risk of acute appendicitis

Given the variability of the predictors used and the lack of multicollinearity between the variables, all assumptions of the regression analysis were met. A multinomial logistic regression analysis was conducted, including all the independent predictors associated with acute appendicitis in order to characterize further the relationship between biomarker levels and the likelihood of acute appendicitis. The analysis showed that CFP was the only significant predictor of acute appendicitis (odds ratio 1·57, 95 per cent c.i. 1·05 to 2·33; P = 0·027) (Table  5 ).

Table 5.

Multinomial logistic regression analysis of different predictors in patients presenting with suspected appendicitis

Odds ratio P
Histologically proven inflamed appendix group
CFP 1·57 (1·05, 2·33) 0·027
CRP 1·01 (0·98, 1·04) 0·410
NLR 1·10 (0·90, 1·35) 0·323
Monocytes 21·57 (0·11, 4089·56) 0·251
Age 0·98 (0·91, 1·05) 0·566
Male sex 1·47 (0·26, 8·32) 0·661
Female sex*
Alternative diagnosis group
CFP 1·40 (0·94, 2·08) 0·092
CRP 1·00 (0·97, 1·03) 0·801
NLR 1·02 (0·82, 1·26) 0·860
Monocytes 16·31 (0·07, 3352·55) 0·304
Age 1·04 (0·98, 1·11) 0·166
Male sex 0·29 (0·05, 1·59) 0·155
Female sex*

Values in parentheses are 95 per cent confidence intervals. Reference categories were values from the histologically proven normal appendix group.

*

Female sex was not included as it was a redundant parameter. CFP, circulating fibrocyte percentage; CRP, C‐reactive protein; NLR, neutrophil : lymphocyte ratio.

Discussion

This study found that the CFP of circulating white cells was increased significantly in patients with histologically proven appendicitis, compared with CFP in patients with a histologically normal appendix. Thus, increases in the proportion of fibrocytes in circulating white cells may be of diagnostic value in patients presenting with suspected appendicitis. The study also found that the diagnostic accuracy of CFP was similar to that of other commonly measured serological biomarkers used in the diagnosis of acute appendicitis such as WCC and CRP. Furthermore, when regression analysis was performed on these biomarkers, including CFP, age and sex, only CFP was retained as an independent prognostic determinant of acute appendicitis. Thus, CFP may provide useful diagnostic information in the diagnosis of acute appendicitis.

The role of CFP in acute appendiceal inflammation has not previously been assessed. This study demonstrates not only that CFP is increased in patients with acute appendicitis, but that the proportion of fibrocytes in circulating white cells may be of diagnostic value in patients presenting with suspected appendicitis. The CFP increases in response to systemic and localized inflammatory conditions 32 , 40 , 41 , 42 . Circulating fibrocytes contribute to the intestinal mesenchymal cells, which comprise a spectrum of cell types that are similar in origin, function and molecular markers. However, fibrocytes are unique because they express both haematopoietic and mesenchymal cell markers 43 , 44 . They can differentiate into myelofibrocytes, fibroblasts and adipocytes (as well as other cell types). Circulating fibrocytes are believed to be stimulated in response to injury of the gut mucosa 45 . Proinflammatory cytokines such as IL‐6 and TNF‐β are the main two components involved in recruiting leucocytes into the injured gut mucosa. In addition, the chemokine receptors CXCR4 and CCR7 are reported to be pivotal for the recruitment of fibrocytes to injured sites 46 , 47 .

Accurate biomarkers that help with the diagnosis of acute appendicitis are lacking; WCC and CRP are the biomarkers commonly used to aid in the diagnosis of acute appendicitis 9 . These biomarkers are associated with low cost 48 , but they are limited in terms of diagnostic accuracy 49 , 50 . Emerging biomarkers in acute appendicitis include IL‐6, procalcitonin and urinary serotonin levels 11 , 16 . Although these have shown good diagnostic potential, they are costly 48 , and thus are not currently in standard use in clinical practice.

A recent study 51 from the Right Iliac Fossa Treatment (RIFT) study group evaluated different models to identify low‐risk patients who are unlikely to have acute appendicitis. This validated 15 risk prediction models in both women and men aged 16–45 years in the UK. The models evaluated were based on clinical history, examination, imaging and biochemical tests. Of the models, the Adult Appendicitis Score achieved the highest specificity in identifying women at low risk of acute appendicitis, whereas the Appendicitis Inflammatory Response score was the optimal model in men 52 , 53 . Hence, specific prediction models can help to identify patients at low risk of acute appendicitis and thereby reduce the NAR. The present study shows that CFP is a predictor of acute appendicitis. It remains to be determined whether its potential utility varies between low‐ and high‐risk groups.

At present, CT is the most sensitive and specific test for the diagnosis of acute appendicitis. However, there are concerns regarding the cost‐effectiveness, accessibility and risks of radiation, and evidence that radiation from standard CT in younger patients is associated with an increased risk of soft tissue and haematological malignancy 54 . Moreover, CT is not available routinely in emergency departments. Although the CFP alone may not be as accurate as CT, it is feasible that its combination with other biomarkers could provide a scoring system with similar accuracy. This is an area for future study.

This study is limited in that it was a single‐centre, cohort‐based study, and did not include children as they may have a different haematological profile. The time taken to process one sample is currently 4 h, because of the different reagents and antibodies involved in the process. However, the potential of the CFP supports development of a point‐of‐care methodology. This could have clinical utility across a range of abdominal inflammatory conditions, not just appendicitis.

Supporting information

Appendix S1: Supporting information

Acknowledgements

This work was supported by the Graduate Entry Medical School (University of Limerick) Strategic Research Fund.

Disclosure: The authors declare no conflict of interest.

Funding information

Graduate Entry Medical School (University of Limerick) Strategic Research Fund

References

  • 1. Di Saverio S, Birindelli A, Kelly MD, Ceresoli M, Augustin G, Gori A et al WSES Jerusalem guidelines for diagnosis and treatment of acute appendicitis. World J Emerg Surg 2016: 11: 34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Sehgal R, Connelly TM, Mohan HM, Byrnes GJ, Peirce C, Coffey JC. The importance of the mesentery in emergency general surgery: ignore the mesentery at your peril. Mesent Periton 2018: 2: 4. [Google Scholar]
  • 3. Fagerstrom A, Paajanen P, Saarelainen H, Ahonen‐Siirtola M, Ukkonen M, Miettinen P et al Non‐specific abdominal pain remains as the most common reason for acute abdomen: 26‐year retrospective audit in one emergency unit. Scand J Gastroenterol 2017; 52: 1072–1077. [DOI] [PubMed] [Google Scholar]
  • 4. Gilmore OJ, Browett JP, Griffin PH, Ross IK, Brodribb AJ, Cooke TJ et al Appendicitis and mimicking conditions. A prospective study. Lancet 1975; 2: 421–424. [DOI] [PubMed] [Google Scholar]
  • 5. Cervellin G, Mora R, Ticinesi A, Meschi T, Comelli I, Catena F et al Epidemiology and outcomes of acute abdominal pain in a large urban emergency department: retrospective analysis of 5340 cases. Ann Transl Med 2016; 4: 362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Zarog MA, O'Leary DP, Levins KJ, Byrnes GJ. Abdominal compartment syndrome secondary to megarectum and megasigmoid. BMJ Case Rep 2018; 2018: bcr2017224097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Maloney C, Edelman MC, Bolognese AC, Lipskar AM, Rich BS. The impact of pathological criteria on pediatric negative appendectomy rate. J Pediatr Surg 2019; 54: 1794–1799. [DOI] [PubMed] [Google Scholar]
  • 8. Tseng J, Cohen T, Melo N, Alban RF. Imaging utilization affects negative appendectomy rates in appendicitis: an ACS‐NSQIP study. Am J Surg 2019; 217: 1094–1098. [DOI] [PubMed] [Google Scholar]
  • 9. Panagiotopoulou IG, Parashar D, Lin R, Antonowicz S, Wells AD, Bajwa FM et al The diagnostic value of white cell count, C‐reactive protein and bilirubin in acute appendicitis and its complications. Ann R Coll Surg Engl 2013; 95: 215–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Sand M, Bechara FG, Holland‐Letz T, Sand D, Mehnert G, Mann B. Diagnostic value of hyperbilirubinemia as a predictive factor for appendiceal perforation in acute appendicitis. Am J Surg 2009; 198: 193–198. [DOI] [PubMed] [Google Scholar]
  • 11. Eriksson S, Granstrom L, Olander B, Wretlind B. Sensitivity of interleukin‐6 and C‐reactive protein concentrations in the diagnosis of acute appendicitis. Eur J Surg 1995; 161: 41–45. [PubMed] [Google Scholar]
  • 12. Yilmaz FM, Yilmaz G, Erol MF, Koklu S, Yucel D. Nitric oxide, lipid peroxidation and total thiol levels in acute appendicitis. J Clin Lab Anal 2010; 24: 63–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Beliaev AM, Booth M. C‐reactive protein measurement is not associated with an improved management of acute cholecystitis: a plié for a change. J Surg Res 2015; 198: 93–98. [DOI] [PubMed] [Google Scholar]
  • 14. Abbas MH, Choudhry MN, Hamza N, Ali B, Amin AA, Ammori BJ. Admission levels of serum amyloid a and procalcitonin are more predictive of the diagnosis of acute appendicitis compared with C‐reactive protein. Surg Laparosc Endosc Percutan Tech 2014; 24: 488–494. [DOI] [PubMed] [Google Scholar]
  • 15. Atema JJ, Gans SL, Beenen LF, Toorenvliet BR, Laurell H, Stoke J et al Accuracy of white blood cell count and C‐reactive protein levels related to duration of symptoms in patients suspected of acute appendicitis. Acad Emerg Med 2015; 22: 1015–1024. [DOI] [PubMed] [Google Scholar]
  • 16. Yu CW, Juan LI, Wu MH, Shen CJ, Wu JY, Lee CC. Systematic review and meta‐analysis of the diagnostic accuracy of procalcitonin, C‐reactive protein and white blood cell count for suspected acute appendicitis. Br J Surg 2013; 100: 322–329. [DOI] [PubMed] [Google Scholar]
  • 17. Beecher SM, Hogan J, O'Leary DP, McLaughlin R. An appraisal of inflammatory markers in distinguishing acute uncomplicated and complicated appendicitis. Dig Surg 2016; 33: 177–181. [DOI] [PubMed] [Google Scholar]
  • 18. Markar SR, Karthikesalingam A, Falzon A, Kan Y. The diagnostic value of neutrophil: lymphocyte ratio in adults with suspected acute appendicitis. Acta Chir Belg 2010; 110: 543–547. [PubMed] [Google Scholar]
  • 19. Mittal MK. Appendicitis: role of MRI. Pediatr Emerg Care 2019; 35: 63–66. [DOI] [PubMed] [Google Scholar]
  • 20. Tamini N, Santurro L, Chiappetta MF, Gattuso I, Barbieri C, Fattori L et al Morbidity after negative appendectomy: a single‐centre experience on 627 cases. Eur J Trauma Emerg Surg 2020; 46: 859–864. [DOI] [PubMed] [Google Scholar]
  • 21. Topin F, Thierry AL, Catrevaux O, Barnoux T, Menguy P, Bertani A et al Diagnostic accuracy of emergency physician‐performed ultrasound for acute appendicitis in a remote location. J Emerg Med 2016; 50: 859–867. [DOI] [PubMed] [Google Scholar]
  • 22. Shogilev DJ, Duus N, Odom SR, Shapiro NI. Diagnosing appendicitis: evidence‐based review of the diagnostic approach in 2014. West J Emerg Med 2014; 15: 859–871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Liese J, Halbinger TM, Ulrich F, Bechstein WO, Strey CW. Appendicitis – the balance between cost effectiveness and safety remains challenging. Lang Arch Surg 2014; 399: 493–501. [DOI] [PubMed] [Google Scholar]
  • 24. Kim K, Kim YH, Kim SY, Kim S, Lee YL, Kim KP et al Low‐dose abdominal CT for evaluating suspected appendicitis. N Engl J Med 2012; 366: 1596–1605. [DOI] [PubMed] [Google Scholar]
  • 25. Sippola S, Virtanen J, Tammilehto V, Grönroos J, Hurme S, Niiniviita H et al The accuracy of low‐dose computed tomography protocol in patients with suspected acute appendicitis: the OPTICAP study. Ann Surg 2020; 271: 332–338. [DOI] [PubMed] [Google Scholar]
  • 26. Pelin M, Paquette B, Revel L, Landecy M, Bouveresse S, Delabrousse E. Acute appendicitis: factors associated with inconclusive ultrasound study and the need for additional computed tomography. Diagn Interv Imaging 2018; 99: 809–814. [DOI] [PubMed] [Google Scholar]
  • 27. Kim DW, Suh CH, Yoon HM, Kim JR, Jung AY, Lee JS et al Visibility of normal appendix on CT, MRI, and sonography: a systematic review and meta‐analysis. AJR Am J Roentgenol 2018; 211: W140–W150. [DOI] [PubMed] [Google Scholar]
  • 28. Xu J, Kisseleva T. Bone marrow‐derived fibrocytes contribute to liver fibrosis. Exp Biol Med (Maywood) 2015; 240: 691–700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM. Differentiation of human circulating fibrocytes as mediated by transforming growth factor‐beta and peroxisome proliferator‐activated receptor gamma. J Biol Chem 2007; 282: 22 910–22 920. [DOI] [PubMed] [Google Scholar]
  • 30. Grieb G, Bucala R. Fibrocytes in fibrotic diseases and wound healing. Adv Wound Care 2012; 1: 36–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199–210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Coffey CJ, Kiernan MG, Sahebally SM, Jarrar A, Burke JP, Kiely PA et al Inclusion of the mesentery in ileocolic resection for Crohn's disease is associated with reduced surgical recurrence. J Crohns Colitis 2018; 12: 1139–1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Wolters PJ, Collard HR, Jones KD. Pathogenesis of idiopathic pulmonary fibrosis. Ann Rev Pathol 2014; 9: 157–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Shipe R, Burdick MD, Strieter BA, Liu L, Shim YM, Sung S‐S et al Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity. J Allergy Clin Immunol 2016; 137: 750–757.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Sahebally SM, Burke JP, Chang KH, Kiernan MG, O'Connell PR, Coffey JC. Circulating fibrocytes and Crohn's disease. Br J Surg 2013; 100: 1549–1556. [DOI] [PubMed] [Google Scholar]
  • 36. Coffey JC, O'Leary DP. The mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 2016; 1: 238–247. [DOI] [PubMed] [Google Scholar]
  • 37. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005; 304: 81–90. [DOI] [PubMed] [Google Scholar]
  • 38. Brenner DA, Kisseleva T, Scholten D, Cong M, Moore‐Morris TJ, Park TJ et al Origin of myofibroblasts in liver fibrosis. Fibrogenesis Tissue Repair 2012; 5: S17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Abu El‐Asrar AM, Struyf S, Van Damme J, Geboes K. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 2008; 92: 699–704. [DOI] [PubMed] [Google Scholar]
  • 40. Kuroda N, Masuya M, Tawara I, Tsuboi J, Yoneda M, Nishikawa K et al Infiltrating CCR2(+) monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP‐1. Sci Rep 2019; 9: 8568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Giuffrida P, Pinzani M, Corazza GR, Di Sabatino A. Biomarkers of intestinal fibrosis – one step towards clinical trials for stricturing inflammatory bowel disease. United European Gastroenterol J 2016; 4: 523–530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Popkharitov AI, Chomov GN. Mesenteric panniculitis of the sigmoid colon: a case report and review of the literature. J Med Case Rep 2007; 1: 108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Quan TE, Cowper S, Wu S‐P, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen‐secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36: 598–606. [DOI] [PubMed] [Google Scholar]
  • 44. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow‐derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87: 858–870. [DOI] [PubMed] [Google Scholar]
  • 45. Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease – current knowledge and future perspectives. J Crohns Colitis 2008; 2: 279–290. [DOI] [PubMed] [Google Scholar]
  • 46. Dupin I, Contin‐Bordes C, Berger P. Fibrocytes in asthma and chronic obstructive pulmonary disease: variations on the same theme. Am J Resp Cell Mol Biol 2018; 58: 288–298. [DOI] [PubMed] [Google Scholar]
  • 47. Wang C‐H, Huang C‐D, Lin H‐C, Lee K‐Y, Lin S‐M, Liu C‐Y et al Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am J Respir Crit Care Med 2008; 178: 583–591. [DOI] [PubMed] [Google Scholar]
  • 48. Acharya A, Markar SR, Ni M, Hanna GB. Biomarkers of acute appendicitis: systematic review and cost–benefit trade‐off analysis. Surg Endosc 2017; 31: 1022–1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Panagiotopoulou IG, Parashar D, Lin R, Antonowicz S, Wells AD, Bajwa FM et al The diagnostic value of white cell count, C‐reactive protein and bilirubin in acute appendicitis and its complications. Ann R Coll Surg Engl 2013; 95: 215–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Dayawansa NH, Segan JD, Yao HH, Chong HI, Sitzler PJ. Incidence of normal white cell count and C‐reactive protein in adults with acute appendicitis. ANZ J Surg 2018; 88: E539–E543. [DOI] [PubMed] [Google Scholar]
  • 51. Bhangu A; RIFT Study Group on behalf of the West Midlands Research Collaborative . Evaluation of appendicitis risk prediction models in adults with suspected appendicitis. Br J Surg 2020; 107: 73–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Andersson M, Andersson RE. The appendicitis inflammatory response score: a tool for the diagnosis of acute appendicitis that outperforms the Alvarado score. World J Surg 2008; 32: 1843–1849. [DOI] [PubMed] [Google Scholar]
  • 53. Sammalkorpi HE, Mentula P, Leppäniemi A. A new adult appendicitis score improves diagnostic accuracy of acute appendicitis – a prospective study. BMC Gastroenterol 2014; 14: 114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Smith‐Bindman R, Lipson J, Marcus R, Kim K‐P, Mahesh M, Gould R et al Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169: 2078–2086. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix S1: Supporting information


Articles from BJS Open are provided here courtesy of Oxford University Press

RESOURCES